The validity and reliability study of the scale in Turkish produced Cronbach's alpha value of 0.90.19
EORTC QLQ-C30 has 30 items and three subscales: general wellness, functional difficulties, and symptom control.
Correlation analyses were performed using the results of the scale with the results of SF-12,
EORTC QLQ-C30, DASH, LEFS scales.
The
EORTC QLQ-C30 questionnaire is a survey conducted to evaluate the quality of life in patients with breast cancer.
The European Organization for Research and Treatment of Cancer Quality-of-Life Questionnaire C-30: The questionnaire developed by
EORTC, and the
EORTC QLQ C-30 Version 3.0 is a quality of life questionnaire commonly used for cancer patients all over the world.
One of the main limitations for the generalization of study results is that QoL in the special population of patients with UM has been explored with instruments, such as the
EORTC QLQ-C30 that investigates general factors related to subjective well-being.
In order to evaluate changes in the participants' health-related quality of life, we used the
EORTC QLQ-C30 questionnaire and its module QLQ-BR23.
EORTC QLQ C-30 [8] (generic questionnaire) and
EORTC QLQ CX-24 [9] (specific questionnaire) was used.
(14.)
EORTC, inventor;
EORTC Quality of Life Group, assignee.
Before and after intervention, quality of life of patients was assessed by
EORTC QLQ-C30.
European Organization for Research and Treatment Quality of Life Version 3.0 Questionnaire (
EORTC QLQC-30).
Recently, eribulin has been included also in an European Organization for Research and Treatment Cancer (
EORTC) Phase 2 study of patients with STS and has been approved by the FDA for the treatment of liposarcomas [4, 9].